X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2142) 2142
Publication (221) 221
Book Review (105) 105
Newspaper Article (46) 46
Book Chapter (39) 39
Book / eBook (20) 20
Newsletter (19) 19
Magazine Article (18) 18
Reference (7) 7
Trade Publication Article (6) 6
Conference Proceeding (3) 3
Dissertation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1626) 1626
index medicus (1091) 1091
female (698) 698
herpes zoster (609) 609
male (592) 592
vaccination (553) 553
aged (552) 552
middle aged (506) 506
herpes zoster - prevention & control (495) 495
shingles (488) 488
vaccines (485) 485
herpes-zoster (453) 453
immunology (447) 447
adult (389) 389
postherpetic neuralgia (371) 371
immunization (325) 325
child (317) 317
health aspects (307) 307
herpes zoster - epidemiology (301) 301
infectious diseases (298) 298
prevention (296) 296
epidemiology (294) 294
varicella (284) 284
infections (280) 280
viruses (273) 273
antiviral agents - therapeutic use (270) 270
chickenpox (268) 268
risk factors (263) 263
herpes zoster vaccine - administration & dosage (257) 257
herpes viruses (251) 251
chickenpox - prevention & control (248) 248
virus diseases (248) 248
adolescent (245) 245
vaccine (239) 239
aged, 80 and over (238) 238
herpesvirus 3, human - immunology (235) 235
united-states (232) 232
child, preschool (227) 227
medicine, general & internal (218) 218
chicken pox (217) 217
incidence (214) 214
infection (213) 213
animals (206) 206
infant (204) 204
adults (202) 202
children (202) 202
herpes zoster - immunology (193) 193
chickenpox vaccine - administration & dosage (188) 188
medicine, research & experimental (179) 179
research (178) 178
care and treatment (173) 173
varicella-zoster virus (173) 173
safety (167) 167
analysis (165) 165
virus (165) 165
pharmacology & pharmacy (164) 164
age (163) 163
pain (161) 161
herpes zoster - complications (157) 157
acyclovir (152) 152
herpes zoster - drug therapy (152) 152
herpes-simplex-virus (152) 152
pediatrics (151) 151
virology (147) 147
double-blind (142) 142
microbiology (139) 139
efficacy (135) 135
medicine & public health (135) 135
influenza (133) 133
older-adults (130) 130
abridged index medicus (128) 128
chickenpox - epidemiology (128) 128
dermatology (128) 128
herpes zoster vaccine - immunology (128) 128
immunogenicity (127) 127
drug therapy (126) 126
treatment outcome (125) 125
herpes simplex (122) 122
disease (120) 120
herpes zoster - diagnosis (120) 120
medical research (119) 119
young adult (119) 119
pregnancy (116) 116
risk (116) 116
article (114) 114
chickenpox vaccine - immunology (114) 114
cost-effectiveness (114) 114
internal medicine (114) 114
age factors (113) 113
antiviral agents (113) 113
dosage and administration (112) 112
immunity (112) 112
united states (112) 112
studies (111) 111
herpes zoster vaccine (110) 110
infant, newborn (110) 110
acyclovir - therapeutic use (109) 109
herpes simplex virus (109) 109
varicella zoster virus (106) 106
allergy and immunology (105) 105
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2189) 2189
German (38) 38
French (23) 23
Spanish (10) 10
Japanese (6) 6
Italian (5) 5
Turkish (3) 3
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 22, pp. 2087 - 2096
Journal Article
Journal of Drugs in Dermatology, ISSN 1545-9616, 11/2011, Volume 10, Issue 11, pp. 1328 - 1330
The development of autoimmune disorders and an increase in autoimmune phenomena have been reported following vaccinations in a number of cases. Blistering skin... 
INFLUENZA VACCINATION | VULGARIS | AUTOIMMUNITY | DERMATOLOGY | Humans | Male | Aged | Pemphigoid, Bullous - etiology | Herpes Zoster Vaccine - adverse effects | Pemphigoid, Bullous - immunology | Herpes Zoster Vaccine - administration & dosage
Journal Article
by Bastidas, A and de la Serna, J and El Idrissi, M and Oostvogels, L and Quittet, P and Lopez-Jimenez, J and Vural, F and Pohlreich, D and Zuckerman, T and Issa, NC and Gaidano, G and Lee, JJ and Abhyankar, S and Solano, C and de Oteyza, JP and Satlin, MJ and Schwartz, S and Campins, M and Rocci, A and Llamas, CV and Lee, DG and Tan, SM and Johnston, AM and Grigg, A and Boeckh, MJ and Campora, L and Lopez-Fauqued, M and Heineman, TC and Stadtmauer, EA and Sullivan, KM and Alonso, AA and Anagnostopoulos, A and Andreadis, C and Angelopoulou, M and Anttila, VJ and Aoun, M and Barista, I and Berkahn, L and Bloor, AJC and Broady, R and Brossart, P and Buadi, FK and Bulabois, CE and Cantin, G and Cellini, C and Chandrasekar, PH and Chauncey, T and Cuneo, A and Dadwal, SS and Dickinson, M and Eom, H and Sanfeliu, AE and Coll, CF and Flomenberg, PR and Gonzalez-Rodriguez, AP and Gottlieb, DJ and Grisariu, S and Guenther, A and Gutman, J and Hahn, U and Heinz, WJ and Heras, I and Ikeda, T and Jarque, I and Karthaus, M and Kerre, T and Kiani, A and Klein, AK and Kofla, G and Kryuchkova, IV and Kuo, CY and Kuruvilla, J and Kuvshinov, A and Kwak, JY and Lee, JH and Lepretre, S and Lie, AKW and Lucchesi, A and Maertens, J and Marijt, EWA and Munoz, CM and Michieli, M and Milliken, ST and Milpied, N and Coll, JM and Mossad, SB and Murphy, J and Matilla, MBN and Novak, J and Olney, HJ and Navarrete, RO and Cascon, MJP and Peniket, A and Penka, G and Piatkowska-Jakubas, B and Zarzuela, MP and Quiel, D and Rowley, SD and Sabry, W and Salmi, TM and ... and ZOE-HSCT Study Grp Collaborators and ZOE-HSCT Study Group Collaborators and for the ZOE-HSCT Study Group Collaborators
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 07/2019, Volume 322, Issue 2, pp. 123 - 133
Journal Article
Drugs & Aging, ISSN 1170-229X, 02/2010, Volume 27, Issue 2, pp. 159 - 176
Individuals who have been infected with varicella zoster virus (VZV) are at risk for developing herpes zoster and this risk appears to be related to a decline... 
Herpes-zoster, prevention | Adis-Drug-Evaluations | Varicella-zoster-virus-vaccine-live, pharmacodynam | Varicella-zoster-virus-vaccine-live, pharmacokinet | Postherpetic-neuralgia, prevention | Varicella-zoster-virus-vaccine-live, therapeutic u | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Varicella-zoster-virus-vaccine-live, pharmacokinetics | Herpes-zoster, Prevention | Varicella-zoster-virus-vaccine-live, pharmacodynamics | Varicella-zoster-virus- vaccine-live, therapeutic use | COST-EFFECTIVENESS | IMMUNOGENICITY | MANAGEMENT | SAFETY | IMMUNE-RESPONSES | PHARMACOLOGY & PHARMACY | GERIATRICS & GERONTOLOGY | Herpes Zoster - prevention & control | Age Factors | Humans | Vaccination | Cost of Illness | Herpesvirus 3, Human - immunology | Vaccines, Attenuated - economics | Incidence | Neuralgia, Postherpetic - prevention & control | Neuralgia, Postherpetic - immunology | Vaccines, Attenuated - administration & dosage | Neuralgia, Postherpetic - epidemiology | Adult | Herpes Zoster - epidemiology | Chickenpox Vaccine - economics | Cost-Benefit Analysis - economics | Herpes Zoster - immunology | Risk Factors | Immunocompetence - immunology | Treatment Outcome | Chickenpox Vaccine - administration & dosage | Health Services for the Aged | Herpes Zoster Vaccine - economics | Herpes Zoster Vaccine - administration & dosage | Randomized Controlled Trials as Topic | Immunity, Cellular - immunology | Antibodies, Viral - immunology | Immunologic Memory | Prevention | Complications and side effects | Shingles (Disease) | Herpesvirus vaccines | Aged | Dosage and administration | Research | Neuralgia | Health aspects | Risk factors
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2012, Volume 55, Issue 10, pp. 1320 - 1328
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2017, Volume 216, Issue 11, pp. 1343 - 1351
The adjuvanted herpes zoster subunit vaccine candidate induces strong humoral and cellular immune responses irrespective of prior vaccination with the live... 
Live attenuated zoster vaccine Zostavax | Herpes zoster | Revaccination | Immune response | Hz/su adjuvanted herpes zoster subunit vaccine | POPULATION | IMMUNITY | INFECTIOUS DISEASES | live attenuated zoster vaccine Zostavax | herpes zoster | EFFICACY | PHASE 1/2 | PREVENTION | TERM PERSISTENCE | MICROBIOLOGY | IMMUNOLOGY | HZ/su adjuvanted herpes zoster subunit vaccine | PATHOGENESIS | immune response | POSTHERPETIC NEURALGIA | VARICELLA | revaccination | CANDIDATE VACCINE | Herpes Zoster - prevention & control | Immunogenicity, Vaccine | Adjuvants, Immunologic - administration & dosage | Immunity, Humoral - immunology | Humans | Herpesvirus 3, Human - immunology | Male | Antibodies, Viral - blood | Herpes Zoster Vaccine - adverse effects | Adjuvants, Immunologic - adverse effects | CD4-Positive T-Lymphocytes - immunology | Immunization, Secondary | Vaccination - methods | Aged, 80 and over | Female | Vaccines, Subunit - adverse effects | Herpes Zoster Vaccine - immunology | Herpes Zoster - immunology | Adjuvants, Pharmaceutic | Vaccines, Subunit - immunology | Drug-Related Side Effects and Adverse Reactions - epidemiology | Herpes Zoster Vaccine - administration & dosage | Immunity, Cellular - immunology | Vaccines, Attenuated - immunology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Aged | Immunology | Viral vaccines | Shingles (Disease) | Vaccination | Patient outcomes | Dosage and administration | Research | Methods | Major and Brief Reports | Editor's Choice | su adjuvanted herpes zoster subunit vaccine
Journal Article